Comparison of mupirocin susceptibility of nasal and nonnasal Staphylococcus aureus isolates.
Susceptibilities of 414 nasal and 586 nonnasal Staphylococcus aureus isolates, both methicillin resistant and methicillin susceptible, to the topical antimicrobial agent mupirocin were compared. A susceptibility of 99.1% was observed for the 1000 isolates. Nasal and nonnasal isolates showed a similar 90% minimum inhibitory concentration (MIC90) and statistically equivalent percent susceptibilities.
Utrup
L J
LJ
Department of Microbial Cell Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406.
Finlay
J E
JE
Rittenhouse
S F
SF
Poupard
J A
JA
D006801:Humans; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D016712:Mupirocin / Q000494:pharmacology*; D009666:Nose / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification
D016712:Mupirocin